The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis
Open accessAbstract
Glycated albumin is thought to more accurately reflect glycemic control in diabetic hemodialysis patients than hemoglobin A(1c) because of shortened red cell survival. To test this, glycated hemoglobin and albumin levels were measured in blood samples collected from 307 diabetic subjects of whom 258 were on hemodialysis and 49 were without overt renal disease. In diabetic subjects with renal disease, relative to those without, the mean serum glucose and glycated albumin concentrations were significantly higher while hemoglobin A(1c) tended to be lower. The glycated albumin to hemoglobin A(1c) ratio was significantly increased in dialysis patients compared with the controls. Hemoglobin A(1c) was positively associated with hemoglobin and negatively associated with the erythropoietin dose in hemodialysis patients, whereas these factors and serum albumin did not significantly impact glycated albumin levels. Using best-fit multivariate models, dialysis status significantly impacted hemoglobin A(1c) levels without a significant effect on glycated albumin. Our results show that in diabetic hemodialysis patients, hemoglobin A(1c) levels significantly underestimate glycemic control while those of glycated albumin more accurately reflect this control.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Practice Point 2.1.2: Accuracy and precision of HbA1c measurement declines with advanced CKD (G4 -G5), particularly among patients treated by dialysis, in whom HbA1c measurements have low reliability.”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [227]
In the citing paper
“Correlations of directly measured blood glucose levels with 3 glycemic biomarkers -HbA1c, glycated albumin, and fructosamine -were progressively weaker with advanced CKD stages (G4 -G5), especially kidney failure treated by dialysis. 196,197,205,210,227”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [227]
Citations
Cites
Adler, A., Stevens, R., Manley, S. E., Bilous, R., Cull, C. A., Holman, R. R., & UKPDS Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00712.x · Cited by 1,800
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s106 · Cited by 1,037
Goldstein, D. E., Little, R. R., Lorenz, R. A., Malone, J. I., Nathan, D., Peterson, C. M., & Sacks, D. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1761 · Cited by 625
Inaba, M., Okuno, S., Kumeda, Y., Yamada, S., Imanishi, Y., Tabata, T., Okamura, M., Okada, S., Yamakawa, T., Ishimura, E., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070772 · Cited by 495
A1C and Survival in Maintenance Hemodialysis Patients
Kalantar‐Zadeh, K., Kopple, J. D., Regidor, D. L., Jing, J., Shinaberger, C. S., Aronovitz, J., McAllister, C. J., Whellan, D. J., & Sharma, K. (2007) · Diabetes Care · doi:10.2337/dc06-2127 · Cited by 258
Impact of Glycemic Control on Survival of Diabetic Patients on Chronic Regular Hemodialysis
Oomichi, T., Emoto, M., Tabata, T., Morioka, T., Tsujimoto, Y., Tahara, H., Shoji, T., & Nishizawà, Y. (2006) · Diabetes Care · doi:10.2337/dc05-1887 · Cited by 190
Kouzuma, T., Uemastu, Y., Usami, T., & Imamura, S. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.02.019 · Cited by 163
Red blood cell survival in chronic renal failure
Ly, J., Marticorena, R. M., & Donnelly, S. M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.06.018 · Cited by 160
Long-term glycemic control measurements in diabetic patients receiving hemodialysis
Joy, M. S., Cefalu, W. T., Hogan, S. L., & Nachman, P. H. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.30549 · Cited by 152
Flagged first, then by citations
1 of the 22 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–321 of 321
Peritoneal Dialysis in Diabetic Patients
Szeto, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-70897-9_19
Sherman, R. A. (2008) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2008.00503.x
(2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328329fcc2
Williams, M. E., & Stanton, R. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00006-9
Ramanathan, K., & Padmanabhan, G. (2014) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2014.076
Hoshino, J., Larkina, M., Karaboyas, A., Bieber, B. A., Ubara, Y., Takaichi, K., Akizawa, T., Akiba, T., Fukuhara, S., Pisoni, R. L., et al. (2018) · Kidney International · doi:10.1016/j.kint.2018.04.018
Wallam, S., Abusamaan, M. S., Clarke, W. A., & Mathioudakis, N. N. (2022) · Clinical Diabetes · doi:10.2337/cd22-0047
Evaluation of plasma glucose control in diabetic patients on hemodialysis a single center study
Razooqi, S. H., Hashimi, R. M. S. A., & Alsodani, M. H. (2022) · Iraq Medical Journal · doi:10.22317/imj.v6i3.1191
Azab, M. M. W., & Mohamed, E. A. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.273063
Glycated albumin and post-transplant diabetes mellitus in kidney transplant recipients
Bleskestad, I. H., Skadberg, Ø., Åsberg, A., & Gøransson, L. G. (2023) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632231152074
García, A. F., Arboleya, Z. C., & Venta, R. (2023) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.05.030
Glycemic control of diabetes dialysis patients and ‘burnt-out diabetes’
Miyasato, K., Takao, N., Maruyama, N., & Abe, M. (2023) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.56.323
Rashed, A.-S. M., Mohamed, R. F., Ghabsha, M. A. A., & Ghoneim, M. S. S. (2023) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.58675/2682-339x.1924
Association between glycated albumin and sudden death in patients undergoing hemodialysis
Kaizu, Y., Nagata, M., Kaizu, S., Qie, Y.-L., Kaizu, K., Tanaka, S., Nakano, T., & Kitazono, T. (2024) · Clinical and Experimental Nephrology · doi:10.1007/s10157-024-02475-w
FATHY, M. D. S. L. A. R. S. A. (2023) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2023.343730
Sarcona, A., Follador, T., & Benson, K. (2025) · Topics in Clinical Nutrition · doi:10.1097/tin.0000000000000380
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis
Berchoux, E., Szwarc, I., Bonnet, J., Pissarra, J., Avignon, A., Jugant, S., Quintrec, M. L., & Sultan, A. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101720
The role of some biochemical markers in the pathogenesis of diabetic nephropathy
Raffik, D. E., Ahmed, A. H., & Raoof, A. A. (2026) · AIP conference proceedings · doi:10.1063/12.0042913
Aihara, M., & Kubota, N. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70447
Rethinking glycemic monitoring: a HTA of glycated albumin for type 2 diabetes with stage IV–V CKD
Ferrario, L. B., & Foglia, E. (2026) · Endocrine · doi:10.1007/s12020-026-04844-9
An evaluation of factors that affect glycaemic control and its measurements in diabetes mellitus
Ng, J. M. (2010) · Repository@Hull (Worktribe) (University of Hull)
Metadata
- Authors
- Peacock, T. P., Shihabi, Z. K., Bleyer, A. J., Dolbare, E. L., Byers, J. R., Knovich, M. A., Calles-Escandon, J., Russell, G. B., & Freedman, B. I.
- Affiliations
- Wake Forest University Health Sciences (US)
- Corresponding author
- Freedman, B.I.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 73
- Issue
- 9
- Pages
- 1062-1068
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2040722615
- Cited by
- 323
- References
- 22
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 6 · 2023: 6 · 2022: 18 · 2021: 11 · 2020: 15 · 2019: 14 · 2018: 19 · 2017: 17 · 2016: 20 · 2015: 26 · 2014: 27 · 2013: 33 · 2012: 24
- FWCI
- 19.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Kidney International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- glycated albumin, HbA1c, glycemic control, diabetes mellitus, hemodialysis, erythropoietin, hemoglobin, serum albumin, kidney disease
- MeSH terms
- Glycated Serum Albumin, Diabetes Mellitus, Female, Renal Dialysis, Glycated Hemoglobin, Humans, Male, Middle Aged, Serum Albumin, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
